SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1409ITEM 1.01 ENTRY INTO MATERIAL DEFINITIVE AGREEMENT. On April 15, 2005 the Icebrg-4/18/2005
1408Neurocrine Announces Submission of New Drug Application for Indiplon Capsules ThIcebrg-4/14/2005
1407Any discussion of Peter Meldrum in context of potential CEO of 2004 was misplacescaram(o)uche-4/12/2005
1406SSB: OPINION We provide a summary of key takeaways from our Smith Barney Healthmopgcw-4/5/2005
1405"The best historical novels ever written..." -The New York Times Book scaram(o)uche-4/2/2005
1404OT and OT: Sales rep, hell, let's put WE in charge of the Madison Ave. accouquidditch-3/31/2005
1403chuckle. (eom)scaram(o)uche-3/31/2005
1402Just trying to cheer myself up. Broke my own rule ('Forever works against ykeokalani'nui-3/31/2005
1401Shareholders might contribute your salary, Pfizer sales rep.scaram(o)uche-3/31/2005
1400<i>A bad taste in the mouth is actually supposed to be one of the definingkeokalani'nui-3/30/2005
1399A bad taste in the mouth is actually supposed to be one of the defining characteIcebrg-3/30/2005
1398This whole Lunesta thing really leaves a bad taste in my mouth.keokalani'nui-3/30/2005
1397Very nice find, Erik. Thanks.keokalani'nui-3/30/2005
1396OHSU scientists test medication to treat involuntary weight loss PORTLAND, Ore.Icebrg-3/30/2005
1395The regulation of feeding and metabolic rate and the prevention of murine cancerIcebrg-3/19/2005
1394Neurocrine Biosciences Announces Positive Phase I Results With Its Orally ActiveIcebrg-3/2/2005
1393Correct - we're ultimately talking about 20% of the expense (100% of 40% vs Biomaven-2/26/2005
1392roger.DewDiligence_on_SI-2/26/2005
1391This is a somewhat complicated, but if I understand this correctly, the effect oIcebrg-2/26/2005
1390Yes, that "rest of world" was wrong. Should have been "remainder Biomaven-2/26/2005
1389Silly nitpicking.tom pope-2/26/2005
1388[From the same 10K]: <i>Starting in 2007, we are required to assume a portDewDiligence_on_SI-2/26/2005
1387From their 10K <i> Beginning in September 2003, and continuing through DeBiomaven-2/26/2005
1386I don't think the androgel copromote is any great shakes. Maybe it will helprkrw-2/26/2005
1385<i>>>Further, ICOS has to assume some sales and marketing responsibiDewDiligence_on_SI-2/26/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News